A new publication discussing LL-37 appeared in the journal Experimental Dermatology, dated August 1, 2026. The publication is titled "Antimicrobial Peptides of the Skin: Roles in Skin Cancer and Clinical Applications." LL-37 remains classified as an unapproved research compound. This publication is indexed with the identifier 42576411 and is available through PubMed. The title indicates the work addresses antimicrobial peptides found in skin, including their roles in skin cancer and potential clinical applications. No specific findings, data, or conclusions from the publication have been provided beyond its title, journal, and publication date. As with any newly indexed publication, readers should consult the full text directly for details on methodology, scope, and any reported results. This brief reports only the existence and bibliographic details of the publication as listed. For general background on LL-37, including its classification and research context, readers can refer to the compound overview.
LL-37 Featured in New Publication on Skin Antimicrobial Peptides
Source: https://pubmed.ncbi.nlm.nih.gov/42576411/